Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
Éric Lemonnier(Laboratoire Pluridisciplinaire de Recherche en Ingénierie des Systèmes, Mécanique et Energétique), Yehezkel Ben‐Ari(Neurochlore (France)), Denis Ravel(Neurochlore (France)), Antoine Rosier(Centre Hospitalier du Rouvray), Nathalie Villeneuve(Henri Gastaut Hospital), Marine Viellard(Hôpital Sainte-Marguerite), P. Brosset(Université de Limoges), Susanne Thümmler(Fondation Lenval), Delphine Bernoux(Centre Hospitalier Le Vinatier), Jean‐Michel Roué(Centre Hospitalier Régional Universitaire de Brest), Stéphane Rondeau(Centre Hospitalier du Rouvray), Sandrine Sonié(Centre Hospitalier Le Vinatier), Sylvie Serret(Fondation Lenval)
Cited by 210
Related Papers
X-Linked Mental Retardation and Autism Are Associated with a Mutation in the NLGN4 Gene, a Member of the Neuroligin Family
|The American Journal of Human Genetics|2004|762
Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring
|Science|2014|587
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
|Nature Genetics|2010|509
A randomised controlled trial of bumetanide in the treatment of autism in children
|Translational Psychiatry|2012|310